Upgrade to SI Premium - Free Trial

Berenberg Downgrades Novo Nordisk (NVO) to Hold

August 12, 2026 3:06 AM
Berenberg analyst Kerry Holford downgraded Novo Nordisk (NYSE: NVO) from Buy to Hold with a price target of $47.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades